Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of California San Francisco
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Antipsychotic Influence on Altered MTL Neuronal Activity in Schizophrenia
Effects of leukofiltration on cells experimentally infec
Multidrug Resistant (MDR) Genes in Rodent Malaria
Magnetically Actuated Active Tuning of Plasmonic Nanostructures
Using the Theory of Successful Intelligence as a Framework for Developing Assessments in AP Physics and Biology
Recently added grants:
Attachment and Biobehavioral Catch-up with Child Protective Services-Involved Parents: Testing Effectiveness in the Community
The role of linear ubiquitination in memory formation
Measuring the Multilevel Outcomes of Children's Mental Health Services Implementation
Circuit mechanisms of self-organized cognitive strategies
Mechanisms of Shear Induction of Blood-Brain Barrier Phenotypes in Human iPSC-derived Brain Endothelial Progenitors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-005
Application #
6688651
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant